Sponsor Pipeline

Fujian Shengdi Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
30
Active Trials
16
Recruiting
8
Phase 3
8
Disease Areas
13
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07297797
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
Enrollment closed, study ongoing
2026-08-01 NCT07297797
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
date change Primary completion pushed: 2026-07 -> 2026-12
2026-08-01 NCT07559136
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of…
Recruitment opened
2026-08-01 NCT07559136
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of…
date change Primary completion pushed: 2027-01 -> 2027-02
2026-07-31 NCT06649344
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin…
Trial completed
2026-07-31 NCT06649344
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin…
date change Primary completion moved earlier: 2026-09-30 -> 2026-07-18
2026-07-31 NCT06649344
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin…
date change Completion moved earlier: 2026-09-30 -> 2026-07-18
2026-07-25 NCT07606950
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients…
Recruitment opened
2026-07-24 NCT07599410
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in…
Recruitment opened
2026-07-22 NCT07670884
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or…
Recruitment opened
2026-07-22 NCT07670884
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or…
Enrollment increased: 425 -> 675 participants
2026-07-22 NCT07670884
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or…
date change Primary completion pushed: 2027-07 -> 2027-10-31
2026-07-22 NCT07670884
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or…
date change Completion pushed: 2027-08 -> 2027-11-30
Active Trials by Phase
Phase 3
8
Phase 2
14
Phase 1
8
Active Trials — top 25 of 30
NCT IDTitleConditionStatus
Phase 3
NCT06974851 A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects… Bstructive Sleep Apnea (OSA) and Obesity Recruiting
NCT07060456 Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal… Type 2 Diabetes Recruiting
NCT06994650 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to… Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy Recruiting
NCT07551492 A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With… Atherosclerotic Cardiovascular Disease Recruiting
NCT07606950 Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients… Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B Recruiting
NCT07670884 A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or… Chronic Management of Body Weight Recruiting
NCT07285902 A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection… Obesity Active, Not Recruiting
NCT07709910 A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis Participants With Obesity and Knee Osteoarthritis Not Yet Recruiting
Phase 2
NCT06425341 A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and… Chronic Hepatitis B Recruiting
NCT07308392 Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in… Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis Recruiting
NCT07318103 Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced… Fluid Retention Caused by Heart Failure Recruiting
NCT07599410 A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in… T2DM Recruiting
NCT06565871 A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea Weight Management Not Yet Recruiting
NCT06595797 A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical… Obese Subjects With Polycystic Ovary Syndrome (PCOS) Not Yet Recruiting
NCT06391710 HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction Heart Failure With Preserved Ejection Fraction Active, Not Recruiting
NCT07185776 A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for… Lipoprotein Disorder Active, Not Recruiting
NCT07100418 A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With… Hyperlipidemia Active, Not Recruiting
NCT07660848 A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic… Metabolic Dysfunction-Associated Steatohepatitis (MASH) Not Yet Recruiting
NCT07233070 HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. Acute Ischemic Stroke Active, Not Recruiting
NCT07690826 A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity Overweight or Obesity Not Yet Recruiting
NCT07709897 A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for… Prevention of Postoperative Nausea and Vomiting Not Yet Recruiting
NCT07297797 Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension Mild to Moderate Hypertension Active, Not Recruiting
Phase 1
NCT07117474 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous… Subjects With Mild Hypertension Recruiting
NCT06934408 A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Obesity Recruiting
NCT07150962 Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in… Overweight or Obesity Recruiting
See all 30 active Fujian Shengdi Pharmaceutical Co., Ltd. trials with filters →
Disease Areas
Get alerts when Fujian Shengdi Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free